CORC

浏览/检索结果: 共10条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Everolimus for the treatment of advanced gastrointestinal or lung nonfunctional neuroendocrine tumors in East Asian patients: a subgroup analysis of the RADIANT-4 study 期刊论文
2019, 卷号: 12, 页码: 1717-1728
作者:  Yao, James C.;  Oh, Do-Youn;  Qian, Jiaming;  Park, Young Suk;  Herbst, Fabian
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
Results of a Randomized, Double- Blind, Placebo- Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 4
作者:  Xu, Jianming;  Kim, Tae Won;  Shen, Lin;  Sriuranpong, Virote;  Pan, Hongming
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2018, 卷号: Vol.13 No.10, 页码: 1539-1548
作者:  Wu, Yi-Long;  Lu, Shun;  Lu, You;  Zhou, Jianying;  Shi, Yuan-kai
收藏  |  浏览/下载:7/0  |  提交时间:2019/02/25
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer 期刊论文
2018, 卷号: 13, 期号: 10, 页码: 1539-1548
作者:  Wu, Yi-Long;  Lu, Shun;  Lu, You;  Zhou, Jianying;  Shi, Yuan-kai
收藏  |  浏览/下载:6/0  |  提交时间:2020/01/03
Phase 3 study of first-line crizotinib vs pemetrexed-cisplatin/carboplatin (PCC) in East Asian patients (pts) with ALK plus advanced non-squamous non-small cell lung cancer (NSCLC). 期刊论文
2016, 卷号: 34, 期号: 15
作者:  Lu, Shun;  Mok, Tony;  Lu, You;  Zhou, Jianying;  Shi, Yuankai
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/04
Phase 3 study of first-line crizotinib vs pemetrexed-cisplatin/carboplatin (PCC) in East Asian patients (pts) with ALK plus advanced non-squamous non-small cell lung cancer (NSCLC). 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Lu, Shun;  Mok, Tony;  Lu, You;  Zhou, Jianying;  Shi, Yuankai
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/04
Adaptation of International Guidelines for Metastatic Colorectal Cancer: An Asian Consensus 期刊论文
CLINICAL COLORECTAL CANCER, 2014, 卷号: 13, 期号: 3
作者:  Cheng, Ann-Lii;  Li, Jin;  Vaid, Ashok K.;  Ma, Brigette Buig Yue;  Teh, Catherine
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/19
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial 期刊论文
2013, 卷号: 14, 期号: 8, 页码: 777-786
作者:  Wu, Yi-Long;  Lee, Jin Soo;  Thongprasert, Sumitra;  Yu, Chong-Jen;  Zhang, Li
收藏  |  浏览/下载:1/0  |  提交时间:2020/01/13
A randomized placebo-controlled phase III study of intercalated erlotinib with gemcitabine/platinum in first-line advanced non-small cell lung cancer (NSCLC): FASTACT-II 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2012-05-20
作者:  Mok, Tony;  Wu, Yi Long;  Thongprasert, Sumitra;  Yu, Chong-Jen;  Zhang, Li
收藏  |  浏览/下载:1/0  |  提交时间:2020/01/13
A randomized placebo-controlled phase III study of intercalated erlotinib with gemcitabine/platinum in first-line advanced non-small cell lung cancer (NSCLC): FASTACT-II 期刊论文
2012, 卷号: 30, 期号: 15
作者:  Mok, Tony;  Wu, Yi Long;  Thongprasert, Sumitra;  Yu, Chong-Jen;  Zhang, Li
收藏  |  浏览/下载:1/0  |  提交时间:2020/01/13


©版权所有 ©2017 CSpace - Powered by CSpace